According to a new study published by the European Journal of Pharmacology, and epublished by the U.S. National Institute of Health, cannabidiol (CBD) reduces airway inflammation and fibrosis in experimental allergic asthma. “Asthma remains a major public health problem and, at present, there are no effective interventions capable of reversing airway remodelling”, states the study’s abstract. … Continue reading Study: CBD Reduces Airway Inflammation and Fibrosis in Experimental Allergic Asthma.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed